Market Closed - OTC Markets 17:44:37 08/07/2025 +04 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for DiaSys Corporation -.--% -

Valuation: DiaSys Corporation

Market Cap 51.44K 45.06K 41.62K 38.43K 72.34K 4.95M 73.79K 497K 195K 2.42M 193K 189K 8.34M P/E 2006
-3.78x
P/E 2007 -3x
Enterprise Value 646K 566K 523K 483K 908K 62.12M 926K 6.24M 2.44M 30.37M 2.43M 2.37M 105M EV / Sales 2006
2.7x
EV / Sales 2007 2.04x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0
10 years 0
Extreme 0
0
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
+1.05%+3.38%+25.56%+0.89% 196B
-6.78%-11.19%-26.52%+7.20% 144B
-0.55%+2.50%+0.66%-17.25% 142B
-4.52%-5.89%-59.14%-19.61% 66.37B
-1.85%-4.99%+15.09%-3.52% 52.85B
-3.57%-1.69%-25.59%-33.03% 45.22B
+0.87%+3.10%+12.59%+12.90% 37.86B
+0.85%+0.39%+23.74%+39.01% 36.64B
-5.59%-4.98%-17.18%-24.64% 29.71B
Average -2.01%-0.08%-5.64%-4.23% 75.09B
Weighted average by Cap. -2.01%-0.32%-2.87%-4.03%

Financials

2006 2007
Net sales 1.69M 1.48M 1.37M 1.26M 2.37M 162M 2.42M 16.31M 6.39M 79.38M 6.34M 6.2M 274M 1.68M 1.47M 1.36M 1.25M 2.36M 161M 2.41M 16.21M 6.35M 78.92M 6.3M 6.16M 272M
Net income -1.05M -918K -848K -783K -1.47M -101M -1.5M -10.12M -3.97M -49.27M -3.94M -3.85M -170M -785K -688K -635K -587K -1.1M -75.53M -1.13M -7.59M -2.97M -36.93M -2.95M -2.88M -127M
Net Debt 302K 264K 244K 226K 425K 29.05M 433K 2.92M 1.14M 14.2M 1.13M 1.11M 48.97M 594K 521K 481K 444K 836K 57.18M 853K 5.74M 2.25M 27.95M 2.23M 2.18M 96.4M
Logo DiaSys Corporation
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
Employees
10
  1. Stock Market
  2. Stocks
  3. DYXC Stock